Literature DB >> 31851805

Personalized Medicine for Primary Treatment of Serous Ovarian Cancer.

Dan L Longo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31851805     DOI： 10.1056/NEJMe1914488

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining.

Authors:  Qin Zhou; Michelle E Howard; Xinyi Tu; Qian Zhu; Janet M Denbeigh; Nicholas B Remmes; Michael G Herman; Chris J Beltran; Jian Yuan; Patricia T Greipp; Judy C Boughey; Liewei Wang; Neil Johnson; Matthew P Goetz; Jann N Sarkaria; Zhenkun Lou; Robert W Mutter
Journal:  Cancer Res       Date:  2021-02-17       Impact factor: 12.701

2.  Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience.

Authors:  Daniela Califano; Daniela Russo; Giosuè Scognamiglio; Nunzia Simona Losito; Anna Spina; Anna Maria Bello; Anna Capiluongo; Francesca Galdiero; Rossella De Cecio; Simona Bevilacqua; Piera Gargiulo; Edoardo Marchesi; Silvana Canevari; Francesco Perrone; Gennaro Daniele; Loris De Cecco; Delia Mezzanzanica; Sandro Pignata
Journal:  Cells       Date:  2020-04-07       Impact factor: 6.600

Review 3.  Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events.

Authors:  Ainhoa Madariaga; Valerie Bowering; Soha Ahrari; Amit M Oza; Stephanie Lheureux
Journal:  Int J Gynecol Cancer       Date:  2020-04-09       Impact factor: 3.437

Review 4.  Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements.

Authors:  Salima Akter; Md Ataur Rahman; Mohammad Nazmul Hasan; Hajara Akhter; Priya Noor; Rokibul Islam; Yoonhwa Shin; M D Hasanur Rahman; Md Shamim Gazi; Md Nazmul Huda; Nguyen Minh Nam; Jinwook Chung; Sunhee Han; Bonglee Kim; Insug Kang; Joohun Ha; Wonchae Choe; Tae Gyu Choi; Sung Soo Kim
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

5.  SWAN pathway-network identification of common aneuploidy-based oncogenic drivers.

Authors:  Robert R Bowers; Christian M Jones; Edwin A Paz; John K Barrows; Kent E Armeson; David T Long; Joe R Delaney
Journal:  Nucleic Acids Res       Date:  2022-04-22       Impact factor: 19.160

6.  Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer.

Authors:  Marina Bagnoli; Roberta Nicoletti; Monica Valitutti; Andrea Rizzo; Alessandra Napoli; Rafaela Montalvão De Azevedo; Antonella Tomassetti; Delia Mezzanzanica
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

7.  Single-cell analysis of copy-number alterations in serous ovarian cancer reveals substantial heterogeneity in both low- and high-grade tumors.

Authors:  Manonmani Kumar; Robert R Bowers; Joe R Delaney
Journal:  Cell Cycle       Date:  2020-10-30       Impact factor: 4.534

8.  A novel workflow for cancer blood biomarker identification.

Authors:  Xiang Wang; Zhiqiang Qiu; Xiangwen Ji; Weihai Ning; Yihua An; Shengdian Wang; Hongwei Zhang
Journal:  Ann Transl Med       Date:  2020-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.